Provectus Biopharmaceuticals, Inc.
Provectus Biopharmaceuticals, Inc. (PVCT) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Provectus Biopharmaceuticals, Inc. (PNK:PVCT).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerPVCT Technical Analysis Summary
Provectus Biopharmaceuticals, Inc. stock currently trades in a neutral range, with no clear dominance from buyers or sellers.
Technical conditions suggest Provectus Biopharmaceuticals, Inc. is consolidating, awaiting a decisive move.
RSI (14): 49.23
Stochastic %K: 31.50
Williams %R: -57.69
Rate of Change (ROC): -5.41
Takeaway:Provectus Biopharmaceuticals, Inc. shows weakening momentum, with sellers gaining the edge.
MACD: 0.00
ADX: 16.54
ATR (14): 0.00
CCI (14): -35.51
Takeaway:Provectus Biopharmaceuticals, Inc. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Provectus Biopharmaceuticals, Inc. trades closer to resistance, supported by stronger momentum within bands.
Takeaway:Provectus Biopharmaceuticals, Inc. trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:PVCT shows bearish money flow, with sellers dominating volume and vigor.
Bullish Signals
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Provectus Biopharmaceuticals, Inc. shows a Neutral outlook — indicators suggest balanced momentum with no clear directional trend.